Cocrystal Pharma (NASDAQ:COCP) Price Target Lowered to $6.00 at HC Wainwright
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) had its price target decreased by equities research analysts at HC Wainwright from $7.00 to $6.00 in a report released on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 302.68% from the stock’s previous […]
